Pharma & Medtech

New business models required
Changing customer requirements and behaviors, innovative technologies and increasing regulatory requirements require new business models that enable pharmaceutical and medtech companies to unlock the full potential of digitization and respond quickly to changing market requirements. Agility, scalability and lean, flexible structures are important prerequisites for the targeted implementation of digital innovations and for successfully holding one's own in a volatile and competitive market.
Pharma & Medtech
Dr. Robert Lettow
Head of Pharma & Medtech
+41 58 411 96 73

Product and production safety thanks to compliance and ICT deployment

The tension between innovation capability and regulatory requirements presents the pharmaceutical and medtech industry with major challenges in terms of technologies and processes. Conventional IT tools and organizational forms are no longer sufficient to meet all requirements. Rather, this requires both industry-specific information technologies and innovative and integrated solutions that guarantee a high degree of security. Digital business models and focused innovation management pave the way for pharmaceutical and medical companies to engage more intensively and directly with patients and open up new, forward-looking business areas and platforms.


The new European Medical Device Regulation (MDR) is a topic that is currently occupying every medtech company. In order to meet the complex requirements of MDR, affected companies will have to be able to track the life cycle of their products along the entire supply chain. In addition to MDR-compliant processes for risk management, this also requires uncompromising quality assurance, which can only be achieved through optimized supplier management and close cooperation with distributors.

How we can assist you:

Our consultants have been working for many years in various mandates for pharmaceutical and medical companies. In addition to innovative technical solutions, they take care of efficient process design and agile handling of often complex projects. The approaches we pursue optimize flexibility, traceability, sustainability, quality and safety equally. In addition, our experts will support you in your operations, for example in the preparation or follow-up of audits and their results. As an independent and product-neutral partner, AWK's customers include renowned pharmaceutical and medical companies such as Novartis, Synthes, Vifor and Bayer. The range of services we offer combines expertise from the fields of project management, ICT consulting, cyber security, data analytics, digitization, compliance, merger & acquisition and divestiture.

PDF | 928.78 KB |

The Customer at the Centre

Published

Computerworld (2019/04)
Download
PDF | 928.78 KB |

Customer Centricity

Published

AWK FOCUS (2019/04)
Download
PDF | 1.67 MB |

Data, data, data - Take advantage of the full potential

AWK FOKUS 2016/10
Download
PDF | 273.39 KB |

Mastering Compliance Requirements with Enterprise Content Management

Download
PDF | 355.43 KB |

Mine your data - A way to a better understanding of the company

Published

AWK KNOWLEDGE (2013/03)

Download
PDF | 495.88 KB |

Cyber security - current trends and protective measures

Published

AWK KNOWLEDGE (2013/06)

Download
PDF | 439.50 KB |

Requirements Engineering - decisive for project success

Published

AWK KNOWLEDGE (2013/09)

Download
PDF | 229.37 KB |

Successful process optimization in practice

Published

AWK KNOWLEDGE (2013/12)

Download
PDF | 796.84 KB |

DLP: For the benefit of your company data

Published

Swiss IT Magazine (2013/09)

Download
PDF | 1.12 MB |

The leverage effect of optimized data management

Published

ICT Communication (2013/02)

Download
PDF | 378.84 KB |

Data centers - successful combination of Swiss strengths

Published

AWK KNOWLEDGE (2012/09)

Download
PDF | 964.83 KB |

Integral Security

Published

Network industry symposium (2014/06)

Download